Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07579442 · ClinicalTrials.gov registry record · NA

Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa (Virtual)

A NA study, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
10
Enrollment target

NCT07579442 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07579442, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The goal of this clinical trial is to evaluate whether a narrative medicine (NM) curriculum can enhance self-expression, reflection, and resilience in adolescents and young adults with anorexia nervosa. The main questions it aims to answer are: * Does participation in an NM curriculum improve self-expression and reflection in individuals with anorexia nervosa? * Does engaging in creative writing and group discussion promote resilience and emotional processing in this population? Participants will be 16-25 years old, medically stable for outpatient eating disorder therapy, and actively engaged in treatment. Those with active suicidal ideation, recent non-suicidal self-injury, or a co-occurring personality disorder will not be eligible. Participants will: * Attend six weekly workshops focused on themes such as self-definition, kindness, resilience, and possibility * Engage in close reading of visual or written texts * Complete creative writing exercises in response to prompts * Participate in group discussions and sharing An optional capstone reading event will provide a supportive space for participants to share their work with peers, loved ones, and providers, fostering connection and community. This study aims to explore the role of narrative medicine in eating disorder treatment and assess its potential benefits for psychological well-being and self-expression.

Interventions

  • BEHAVIORAL Narrative Medicine (NM) Workshop Series

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-07-01
Est. Completion 2027-07-01
Phase NA

What the Registry Record Tells You About NCT07579442

The ClinicalTrials.gov registry entry for NCT07579442 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Narrative Medicine (NM) Workshop Series is the first listed.

NCT07579442 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07579442 about?

NCT07579442 is a clinical study titled "Incorporating Narrative Into the Treatment of Youth With Anorexia Nervosa (Virtual)". The goal of this clinical trial is to evaluate whether a narrative medicine (NM) curriculum can enhance self-expression, reflection, and resilience in adolescents and young adults with anorexia nervosa. The main questions it aims to answer are: * Does participation in an NM curriculum improve self...

What is the current status of trial NCT07579442?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-07-01. Estimated completion is 2027-07-01.

What interventions are being tested in trial NCT07579442?

The interventions under investigation include: Narrative Medicine (NM) Workshop Series (BEHAVIORAL).

Who is sponsoring clinical trial NCT07579442?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.